Zero-cost Radiation Protection Method to Reduce Radiation Exposure of Interventional Cardiologists During Transradial Percutaneous Coronary Procedures (FREEPADRAD Trial)
FREEPADRAD
1 other identifier
interventional
500
1 country
2
Brief Summary
Ionising radiation is a recognised occupational hazard in interventional cardiology. This prospective, randomised trial aims to evaluate the effectiveness of additional radiation protection by existing devices but with a different use, specifically the use of medical lead aprons (designed and used to be worn by the medical and nursing staff for radiation protection) covering the patient's lower abdominal and pelvic area during transradial coronary angiography and angioplasty. The intervention's efficacy will be assessed by measuring the reduction in operator radiation exposure and determining the impact of various clinical and procedural factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 30, 2025
CompletedFirst Submitted
Initial submission to the registry
February 13, 2025
CompletedFirst Posted
Study publicly available on registry
April 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
April 8, 2026
April 1, 2026
1.4 years
February 13, 2025
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Effectiveness of Patient-Applied Pelvic Shielding in Reducing Operator Radiation Exposure During Transradial Coronary Procedures
Primary Outcomes: Absolute Operator Radiation Exposure: Direct measurement of operator exposure (µSv) using a dosimeter placed outside the lead apron at chest level.
During the transradial coronary procedure, measured from the start to the completion of fluoroscopy.
Effectiveness of Patient-Applied Pelvic Shielding in Reducing Operator Radiation Exposure During Transradial Coronary Procedures
Primary Outcomes: Relative Operator Radiation Exposure: Measured as the ratio of operator exposure (µSv) to patient radiation dose area product (cGy·cm²).
During the transradial coronary procedure, measured from the start to the completion of fluoroscopy.
Study Arms (2)
Use of conventional radiation protection measures.
NO INTERVENTIONThis group will undergo transradial coronary procedures using only conventional radiation protection measures. These include standard operator lead aprons, fixed protective drapes, and other standard shielding equipment typically employed in the catheterization laboratory. No additional radiation protection devices or techniques will be applied to the patient. This arm serves as the baseline for comparison with the intervention group.
Additional patient-applied pelvic lead shielding
EXPERIMENTALThis group will undergo transradial coronary procedures with the addition of a patient-applied pelvic lead shield. Alongside the conventional radiation protection measures used in the control group, a triple-layer lead apron will be placed over the patient's lower abdominal and pelvic region. This shield, composed of three 0.25 mm Pb-equivalent layers, is designed to reduce scatter radiation exposure to the operator. The intervention aims to assess the effectiveness of this additional protective measure in reducing operator radiation dose.
Interventions
The intervention involves the application of a triple-layer lead apron to the patient's lower abdominal and pelvic region during transradial coronary procedures. The apron measures 75 cm × 45 cm and is composed of three layers of 0.25 mm Pb-equivalent material. This protective shield is placed on the patient in addition to standard operator radiation protection measures. The primary goal of this intervention is to reduce scatter radiation exposure to the operator, thereby improving occupational safety in the catheterization laboratory. This approach leverages existing radiation protection materials in a novel configuration.
Eligibility Criteria
You may qualify if:
- Patients undergoing transradial diagnostic coronary angiography or angioplasty.
- Adults aged 18 years and older.
- Informed consent provided.
You may not qualify if:
- Acute STEMI requiring primary percutaneous coronary intervention (PCI).
- Patients undergoing structural heart interventions.
- Initially femoral access or crossover to femoral access procedures.
- Patients unable to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
First Department of Cardiology, Hippokration General Hospital of Athens
Athens, Attica, 11527, Greece
First Department of Cardiology, National and Kapodistrian University of Athens, Hippokration General Hospital of Athens
Athens, Attica, 11527, Greece
Related Publications (6)
Shah RM, Patel D, Abbate A, Cowley MJ, Jovin IS. Comparison of transradial coronary procedures via right radial versus left radial artery approach: A meta-analysis. Catheter Cardiovasc Interv. 2016 Dec;88(7):1027-1033. doi: 10.1002/ccd.26519. Epub 2016 Apr 1.
PMID: 27037544RESULTVijayalakshmi K, Kelly D, Chapple CL, Williams D, Wright R, Stewart MJ, Hall JA, Sutton A, Davies A, Haywood J, de Belder MA. Cardiac catheterisation: radiation doses and lifetime risk of malignancy. Heart. 2007 Mar;93(3):370-1. doi: 10.1136/hrt.2006.098731. No abstract available.
PMID: 17322516RESULTGutierrez-Barrios A, Camacho-Galan H, Medina-Camacho F, Canadas-Pruano D, Jimenez-Moreno A, Calle-Perez G, Vazquez-Garcia R. Effective Reduction of Radiation Exposure during Cardiac Catheterization. Tex Heart Inst J. 2019 Jun 1;46(3):167-171. doi: 10.14503/THIJ-17-6548. eCollection 2019 Jun.
PMID: 31708696RESULTSciahbasi A, Piccaluga E, Sarandrea A, Nucci G, Caretto N, Rigattieri S, Fedele S, Romano S, Penco M. Operator Pelvic Radiation Exposure During Percutaneous Coronary Procedures. J Invasive Cardiol. 2018 Feb;30(2):71-74. Epub 2017 Dec 15.
PMID: 29245152RESULTAnadol R, Brandt M, Merz N, Knorr M, Ahoopai M, Geyer M, Krompiec D, Wenzel P, Munzel T, Gori T. Effectiveness of additional X-ray protection devices in reducing scattered radiation in radial intervention: the ESPRESSO randomised trial. EuroIntervention. 2020 Oct 23;16(8):663-671. doi: 10.4244/EIJ-D-19-00945.
PMID: 32338611RESULTVenneri L, Rossi F, Botto N, Andreassi MG, Salcone N, Emad A, Lazzeri M, Gori C, Vano E, Picano E. Cancer risk from professional exposure in staff working in cardiac catheterization laboratory: insights from the National Research Council's Biological Effects of Ionizing Radiation VII Report. Am Heart J. 2009 Jan;157(1):118-24. doi: 10.1016/j.ahj.2008.08.009.
PMID: 19081407RESULT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Cardiology, Principal Investigator, Interventional Cardiologist
Study Record Dates
First Submitted
February 13, 2025
First Posted
April 17, 2025
Study Start
January 30, 2025
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
April 8, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share